Acetylcysteine, Solution for Injection, 100 Mg/Ml Tender - 137599789

Procurement Summary

Country: Ukraine

Summary: Acetylcysteine, Solution for Injection, 100 Mg/Ml, 3 Ml Each; Beclomethasone, Aerosol for Inhalation, 100 Μg/Dose, 200 Doses; Benzathine Benzylpenicillin Powder for Suspension for Injection 1500000 Units; Galloper...

Deadline: 13 Mar 2026

Posting Date: 12 Mar 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 137599789

Document Ref. No.: UA-2026-03-10-009525-a

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: UAH 1991540

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Acetylcysteine, solution for injection, 100 mg/ml, 3 ml each; Beclomethasone, aerosol for inhalation, 100 μg/dose, 200 doses; Benzathine benzylpenicillin powder for suspension for injection 1500000 units; Haloperidol, solution for injection, 5 mg/ml, 1 ml each; Hydroxychloroquine, tablets, 200 mg each; Gliclazide tablets with modified release, 60 mg each; Electrolytes and combinations solution for infusions, 500 ml each; Ringer Lactate solution for infusions of 200 ml; Enoxaparin sodium, solution for injection, 10000 anti-Xa IU/ml, 0.8 ml each; Enoxaparin sodium, solution for injection, 10, 000 anti-Xa IU/ml, 3.0 ml each; Enoxaparin sodium, solution for injection, 10, 000 anti-Xa IU/ml, 0.4 ml each; Epinephrine 1.82 mg/ml, solution for injection, ampoule; Anti-D human immunoglobulin, solution for injections, 300 mcg (1500 IU)/2 ml, 2 ml each; Indapamide, tablets, 1.5 mg each; Insulin aspart (Fast-acting), solution for injection, 100 Units/ml, 3 ml each; Insulin glargine, solution for injection, 100 Units/ml, 3 ml each; Insulin glargine and lixisenatide, solution for injection, 100 Units/ml + 50 μg/ml, 3 ml each; Insulin glargine, solution for injection, 300 Units/ml, 1.5 ml each; Insulin glulisine, solution for injection, 100 Units/ml, 3 ml each; Insulin degludec and liraglutide, solution for injection, 100 units/ml and 3.6 mg/ml, 3 ml each; Insulin degludec, solution for injections, 100 Units/ml, 3 ml each; Human insulin (Combination: 30% Short-acting; 70% Medium-acting), suspension for injection, 100 U/ml, bottle, 10 ml; Potassium chloride solution for infusions/concentrate for ro...

Documents

 Tender Notice